ADVFN appoints Jason Paltrowitz as non-executive director
ADVFN Ltd is pleased to announce the appointment of Jason Paltrowitz as a Non-Executive Director. Jason brings more than 20 years of leadership experience across global capital markets, investor relations, exchange services, and corporate advisory.Listen to the HotCopper podcast for in-depth disc...
Market Cap $16.82M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
Filters
[Clear]
- Price Sensitive: Yes
| CYC | 40 Patient Milestone Achieved For Technegas USFDA Trial | PRICE SENSITIVE | 29/03/18 | |
| CYC | Preliminary Final Report | PRICE SENSITIVE | 26/02/18 | |
| CYC | Dividend/Distribution - CYC | PRICE SENSITIVE | 26/02/18 | |
| CYC 40 Patient Milestone Achieved For Technegas USFDA Trial | |||
| 29/03/18 | PRICE SENSITIVE | ||
| CYC Preliminary Final Report | |||
| 26/02/18 | PRICE SENSITIVE | ||
| CYC Dividend/Distribution - CYC | |||
| 26/02/18 | PRICE SENSITIVE | ||
